Shares in T2 Medical Inc. plunged Wednesday in after-hourstrading following the company's announcement that a grandjury in Atlanta had requested documents. Shares in the Atlantacompany (NASDAQ:TSQM) fell an additional $10.50 a sharefrom a close during normal trading hours at $26.50. T2 Medicalsaid the focus of the grand jury request, apparently made atthe request of the U.S. Department of Health and HumanServices, appears to be related to the continuing debatesurrounding self-referrals of Medicare patients to doctor-owned facilities. T2 manages physician-owned infusion centers.
(c) 1997 American Health Consultants. All rights reserved.